Paper · 26059619
Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system.
Backert S and 2 others. Future Microbiol, 2015. Cited by 163 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Papers, record 26059619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26059619
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genomic Islands | Major topic |
| Helicobacter pylori | Major topic |
| Type IV Secretion Systems | Major topic |
| Antigens, Bacterial | |
| Bacterial Adhesion | |
| Bacterial Proteins | |
| Epithelial Cells | |
| Humans | |
| Models, Biological | |
| Protein Conformation | |
| Protein Multimerization | |
| Protein Transport | |
| Virulence Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI108713 | NIAID NIH HHS | United States | R01AI108713 | PubMed and NIH | NIH RePORTER |
| 1R011AM087 | NIADDK NIH HHS | United States | PubMed | PubMed |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,908,298 | Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22908298 | PubMed |
| 2 | 24,891,108 | Genes required for assembly of pili associated with the Helicobacter pylori cag type IV secretion system. | Infect Immun | 2014 | https://conductscience.org/library/papers/24891108 | PubMed |
| 3 | 12,780,777 | Structural definition on the surface of Helicobacter pylori type IV secretion apparatus. | Cell Microbiol | 2003 | https://conductscience.org/library/papers/12780777 | PubMed |
| 4 | 16,939,533 | Pathogenicity islands: a molecular toolbox for bacterial virulence. | Cell Microbiol | 2006 | https://conductscience.org/library/papers/16939533 | PubMed |
| 5 | 24,097,901 | Echoes of a distant past: The cag pathogenicity island of Helicobacter pylori. | Cold Spring Harb Perspect Med | 2013 | https://conductscience.org/library/papers/24097901 | PubMed |
| 6 | 22,287,591 | Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin-integrin linked kinase signalling complex. | Gut | 2012 | https://conductscience.org/library/papers/22287591 | PubMed |
| 7 | 19,966,800 | Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. | Nat Struct Mol Biol | 2010 | https://conductscience.org/library/papers/19966800 | PubMed |
| 8 | 19,946,264 | Structure of the outer membrane complex of a type IV secretion system. | Nature | 2009 | https://conductscience.org/library/papers/19946264 | PubMed |
| 9 | 2,307,514 | Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. | Infect Immun | 1990 | https://conductscience.org/library/papers/2307514 | PubMed |
| 10 | 24,670,658 | Structure of a type IV secretion system. | Nature | 2014 | https://conductscience.org/library/papers/24670658 | PubMed |
1 to 10 of 65
See all 65 referencesCited by114
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 163 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,963,802 | Evolution and function of genetic polymorphisms in the Helicobacter pylori type IV secretion pilus protein CagL in gastric carcinogenesis. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42963802 | PubMed |
| 42,786,516 | Serial serum interleukin-8 trajectories are associated with progression from Helicobacter pylori-associated precancerous lesions to gastric cancer: a prospective longitudinal cohort study. | Gut Pathog | 2026 | https://conductscience.org/library/papers/42786516 | PubMed |
| 42,772,936 | Beyond PD-L1/PD-1: expression of PVR/TIGIT and TNFRSF14/BTLA axes in response to Helicobacter pylori and in gastric cancer lesions. | Immunohorizons | 2026 | https://conductscience.org/library/papers/42772936 | PubMed |
| 42,642,391 | Deciphering the initiation pathway of CagT4SS assembly by in vitro reconstitution of subcomplexes. | Nat Commun | 2026 | https://conductscience.org/library/papers/42642391 | PubMed |
| 42,531,194 | Mechanistic evaluation of NSC 57774 as a SHP2 inhibitor in gastric cancer: Multi-pathway signaling modulation in vitro. | PLoS One | 2026 | https://conductscience.org/library/papers/42531194 | PubMed |
| 42,336,815 | The "Hit-and-Run" legacy: epigenetic locking and the survival switch in H. pylori-associated gastric cancer. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42336815 | PubMed |
| 42,035,012 | Computational design of a multi-epitope vaccine against Helicobacter pylori targeting CagA, FliD, urease, and OipA with cholera toxin B subunit (CTB) adjuvant. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42035012 | PubMed |
| 41,838,338 | The role of gut microbiota in the development, diagnosis, and treatment of gastric cancer. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/41838338 | PubMed |
| 41,581,762 | Reprogramming host histone modifications by bacterial pathogens. | Mol Cells | 2026 | https://conductscience.org/library/papers/41581762 | PubMed |
| 41,347,241 | Microbial oncogenesis within the gastric niche: how the gastric microbiota influences H. pylori-induced disease progression. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41347241 | PubMed |
1 to 10 of 114
See all 114 cited byGenes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| ADAM17 | 6,868 | PubTator's text mining | https://conductscience.org/library/genes/6868 | NCBI Gene |
| CDC42 | 998 | PubTator's text mining | https://conductscience.org/library/genes/998 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CHUK | 1,147 | PubTator's text mining | https://conductscience.org/library/genes/1147 | NCBI Gene |
| CRK | 1,398 | PubTator's text mining | https://conductscience.org/library/genes/1398 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| CTTN | 2,017 | PubTator's text mining | https://conductscience.org/library/genes/2017 | NCBI Gene |
| CXCL8 | 3,576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| DDX53 | 168,400 | PubTator's text mining | https://conductscience.org/library/genes/168400 | NCBI Gene |
1 to 10 of 35
See all 35 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26059619
GET https://conductscience.org/api/papers/v1/26059619/references?page=2